59th Global Congress on Biomedical and Cancer Research
  • Follow

Conference Sessions

  • Advances in genomics and personalized medicine
  • Stem cell research and regenerative medicine
  • Bioinformatics and computational biology
  • Drug discovery and pharmacology
  • Biomaterials and tissue engineering
  • Respiratory diseases and pulmonary medicine
  • Endocrinology and hormone research
  • Reproductive health and fertility studies
  • Aging and gerontology research
  • Environmental health and toxicology
  • Biochemistry and molecular biology
  • Cell signaling and molecular pathways
  • Epigenetics and gene regulation
  • Imaging techniques in biomedical research
  • Cancer biology and oncology
  • Diabetes research and management
  • Precision medicine and biomarker discovery
  • Health disparities and social determinants of health
  • Public health policy and health economics
  • Clinical trials and regulatory affairs
  • Artificial intelligence in healthcare
  • Synthetic biology and genetic engineering
  • Environmental toxicology and pollution control
  • Oncogenes and tumor suppressor genes
  • Angiogenesis and cancer metastasis
  • Cancer immunotherapy
  • Targeted therapies in cancer treatment
  • Precision oncology
  • Biomarkers for cancer diagnosis and prognosis
  • Liquid biopsies for cancer detection
  • Epigenetics in cancer development
  • Role of inflammation in cancer
  • Cancer genomics and transcriptomics
  • Immunogenomics in cancer immunotherapy
  • Radiation therapy and its mechanisms of action
  • Chemotherapy and drug resistance in cancer
  • Radioimmunotherapy for cancer treatment
  • Immunomodulatory agents in cancer therapy
  • Cancer vaccines and their development
  • Liquid biopsy for monitoring treatment response
  • Circulating tumor cells and their significance
  • Computational modeling of cancer progression
  • Cancer disparities and healthcare access
  • Survivorship and quality of life in cancer patients
  • Palliative care and end-of-life issues
  • Cancer epidemiology and population studies
  • Environmental carcinogens and cancer prevention
  • Pediatric oncology and childhood cancer research
  • Geriatric oncology and cancer in the elderly
  • Rare cancers and orphan drug development
  • Artificial intelligence for early cancer detection
  • Patient-reported outcomes in cancer research
  • Cancer survivorship and long-term effects of treatment